These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors. Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783 [TBL] [Abstract][Full Text] [Related]
5. New Pd-Fe ferrocenyl antiparasitic compounds with bioactive 8-hydroxyquinoline ligands: a comparative study with their Pt-Fe analogues. Rivas F; Medeiros A; Quiroga C; Benítez D; Comini M; Rodríguez-Arce E; Machado I; Cerecetto H; Gambino D Dalton Trans; 2021 Feb; 50(5):1651-1665. PubMed ID: 33449983 [TBL] [Abstract][Full Text] [Related]
6. New heterobimetallic ferrocenyl derivatives: Evaluation of their potential as prospective agents against trypanosomatid parasites and Mycobacterium tuberculosis. Rivas F; Medeiros A; Rodríguez Arce E; Comini M; Ribeiro CM; Pavan FR; Gambino D J Inorg Biochem; 2018 Oct; 187():73-84. PubMed ID: 30055398 [TBL] [Abstract][Full Text] [Related]
7. Comparative high-throughput analysis of the Trypanosoma cruzi response to organometallic compounds. Mosquillo MF; Smircich P; Ciganda M; Lima A; Gambino D; Garat B; Pérez-Díaz L Metallomics; 2020 May; 12(5):813-828. PubMed ID: 32250378 [TBL] [Abstract][Full Text] [Related]
8. Activity of phosphino palladium(II) and platinum(II) complexes against HIV-1 and Mycobacterium tuberculosis. Gama NH; Elkhadir AY; Gordhan BG; Kana BD; Darkwa J; Meyer D Biometals; 2016 Aug; 29(4):637-50. PubMed ID: 27246555 [TBL] [Abstract][Full Text] [Related]
9. Homology modeling of T. cruzi and L. major NADH-dependent fumarate reductases: ligand docking, molecular dynamics validation, and insights on their binding modes. Merlino A; Vieites M; Gambino D; Coitiño EL J Mol Graph Model; 2014 Mar; 48():47-59. PubMed ID: 24370672 [TBL] [Abstract][Full Text] [Related]
10. Bioactivity of pyridine-2-thiolato-1-oxide metal complexes: Bi(III), Fe(III) and Ga(III) complexes as potent anti-Mycobacterium tuberculosis prospective agents. Machado I; Marino LB; Demoro B; Echeverría GA; Piro OE; Leite CQ; Pavan FR; Gambino D Eur J Med Chem; 2014 Nov; 87():267-73. PubMed ID: 25261824 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action. Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864 [TBL] [Abstract][Full Text] [Related]
13. Pt-Fe ferrocenyl compounds with hydroxyquinoline ligands show selective cytotoxicity on highly proliferative cells. Rivas F; Medeiros A; Comini M; Suescun L; Rodríguez Arce E; Martins M; Pinheiro T; Marques F; Gambino D J Inorg Biochem; 2019 Oct; 199():110779. PubMed ID: 31351379 [TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi biochemical changes and cell death induced by an organometallic platinum-based compound. Mosquillo MF; Bilbao L; Hernández F; Tissot F; Gambino D; Garat B; Pérez-Díaz L Chem Biol Drug Des; 2018 Sep; 92(3):1657-1669. PubMed ID: 29745031 [TBL] [Abstract][Full Text] [Related]
15. Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents. Pavan FR; Poelhsitz GV; do Nascimento FB; Leite SR; Batista AA; Deflon VM; Sato DN; Franzblau SG; Leite CQ Eur J Med Chem; 2010 Feb; 45(2):598-601. PubMed ID: 19931948 [TBL] [Abstract][Full Text] [Related]
16. Effect of a new anti-T. cruzi metallic compound based on palladium. Mosquillo MF; Bilbao L; Hernández F; Machado I; Gambino D; Garat B; Pérez-Díaz L Biometals; 2018 Dec; 31(6):961-974. PubMed ID: 30259247 [TBL] [Abstract][Full Text] [Related]
17. Trans influence on the rate of reductive elimination. Reductive elimination of amines from isomeric arylpalladium amides with unsymmetrical coordination spheres. Yamashita M; Cuevas Vicario JV; Hartwig JF J Am Chem Soc; 2003 Dec; 125(52):16347-60. PubMed ID: 14692777 [TBL] [Abstract][Full Text] [Related]
18. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity. Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466 [TBL] [Abstract][Full Text] [Related]
19. Bis(diphenylphosphino)amines-containing ruthenium cymene complexes as potential anti-Mycobacterium tuberculosis agents. da Silva JP; Silva IC; Pavan FR; Back DF; de Araujo MP J Inorg Biochem; 2017 Aug; 173():134-140. PubMed ID: 28521188 [TBL] [Abstract][Full Text] [Related]
20. Computational and Investigative Study of Flavonoids Active Against Typanosoma cruzi and Leishmania spp. Ribeiro FF; Junior FJ; da Silva MS; Scotti MT; Scotti L Nat Prod Commun; 2015 Jun; 10(6):917-20. PubMed ID: 26197515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]